Global Intracranial Hemorrhage Diagnosis & Treatment Market Research Report—Forecast to 2027

Table of Contents

TABLE OF CONTENT 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 SCOPE OF THE STUDY 17 2.2 RESEARCH OBJECTIVE 17 2.3 MARKET STRUCTURE 17 2.4 ASSUMPTIONS & LIMITATIONS 18 3 RESEARCH METHODOLOGY 3.1 DATA MINING 19 3.2 SECONDARY RESEARCH 20 3.3 PRIMARY RESEARCH 21 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 22 3.5 FORECASTING TECHNIQUES 23 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 24 3.6.1 BOTTOM-UP APPROACH 25 3.6.2 TOP-DOWN APPROACH 25 3.7 DATA TRIANGULATION 26 3.8 VALIDATION 26 4 MARKET DYNAMICS 4.1 OVERVIEW 27 4.2 DRIVERS 29 4.2.1 LARGE NUMBER OF PATIENTS SUFFERING FROM BRAIN CANCER, ANEURYSM, AND RELATED CONDITIONS 29 4.2.2 GROWING NUMBER OF INCIDENCES OF TRAUMA AND ACCIDENTS LEADING TO TRAUMATIC BRAIN INJURY (TBI) 29 4.2.3 CLINICAL TRIALS TO IMPROVE AVAILABLE TREATMENTS 30 4.2.4 INCREASING HEALTHCARE EXPENDITURE 30 4.3 RESTRAINTS 31 4.3.1 INCREASING COUNTERFEIT DRUGS & SIDE EFFECTS OF THE TREATMENT 31 4.3.2 LACK OF SKILLED WORKFORCE 32 4.4 OPPORTUNITIES 33 4.4.1 NEW PRODUCT LAUNCH IN DEVELOPING REGIONS 33 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 34 5.1.1 R&D 35 5.1.2 MANUFACTURING 35 5.1.3 DISTRIBUTION AND SALES 35 5.1.4 POST-SALES MONITORING 35 5.2 PORTER’S FIVE FORCES MODEL 36 5.2.1 BARGAINING POWER OF SUPPLIERS 37 5.2.2 BARGAINING POWER OF BUYERS 37 5.2.3 THREAT OF NEW ENTRANTS 37 5.2.4 THREAT OF SUBSTITUTES 37 5.2.5 INTENSITY OF RIVALRY 37 5.3 COVID-19 IMPACT ANALYSIS 38 5.3.1 IMPACT ON GROWTH RATE 38 6 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY TYPE 6.1 OVERVIEW 39 6.2 INTRACEREBRAM HEMORRHAGE 40 6.3 SUBARACHNOID HEMORRHAGE 40 6.4 EPIDURAL HEMATOMA 41 6.5 SUBDURAL HEMATOMA 41 7 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY DIAGNOSIS & TREATMENT 7.1 OVERVIEW 42 7.2 DIAGNOSIS 43 7.3 TREATMENT 44 8 GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET, BY REGION 8.1 OVERVIEW 46 8.2 AMERICAS 47 8.2.1 NORTH AMERICA 50 8.2.1.1 US 53 8.2.1.2 CANADA 56 8.2.2 LATIN AMERICA 58 8.3 EUROPE 60 8.3.1 WESTERN EUROPE 63 8.3.1.1 GERMANY 66 8.3.1.2 FRANCE 68 8.3.1.3 UK 70 8.3.1.4 ITALY 72 8.3.1.5 SPAIN 74 8.3.1.6 REST OF WESTERN EUROPE 76 8.3.2 EASTERN EUROPE 78 8.4 ASIA-PACIFIC 80 8.4.1 CHINA 83 8.4.2 JAPAN 85 8.4.3 INDIA 87 8.4.4 AUSTRALIA 89 8.4.5 SOUTH KOREA 91 8.4.6 REST OF ASIA-PACIFIC 93 8.5 MIDDLE EAST & AFRICA 96 8.5.1 MIDDLE EAST 99 8.5.2 AFRICA 101 9 COMPETITIVE LANDSCAPE 9.1 OVERVIEW 103 9.2 COMPETITIVE ANALYSIS 103 9.3 COMPETITIVE BENCHMARKING 104 9.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 105 9.5 MAJOR GROWTH STRATEGY IN THE GLOBAL INTRACRANIAL HEMORRHAGE DIAGNOSIS & TREATMENT MARKET 105 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 106 9.6.1 PRODUCT APPROVALS 106 9.6.2 ACQUISITIONS 106 9.6.3 AGREEMENTS/COLLABORATIONS 106 10 COMPANY PROFILES 10.1 CANON INC. 107 10.1.1 COMPANY OVERVIEW 107 10.1.2 FINANCIAL OVERVIEW 108 10.1.3 PRODUCTS/SERVICES OFFERED 109 10.1.4 KEY DEVELOPMENTS 109 10.1.5 SWOT ANALYSIS 110 10.1.6 KEY STRATEGIES 110 10.2 FUJIFILM CORPORATION 111 10.2.1 COMPANY OVERVIEW 111 10.2.2 FINANCIAL OVERVIEW 112 10.2.3 PRODUCTS/SERVICES OFFERED 112 10.2.4 KEY DEVELOPMENTS 112 10.2.5 SWOT ANALYSIS 113 10.2.6 KEY STRATEGIES 113 10.3 GE HEALTHCARE 114 10.3.1 COMPANY OVERVIEW 114 10.3.2 FINANCIAL OVERVIEW 115 10.3.3 PRODUCTS/SERVICES OFFERED 116 10.3.4 KEY DEVELOPMENTS 116 10.3.5 SWOT ANALYSIS 117 10.3.6 KEY STRATEGIES 117 10.4 HITACHI, LTD 118 10.4.1 COMPANY OVERVIEW 118 10.4.2 FINANCIAL OVERVIEW 118 10.4.3 PRODUCTS/SERVICES OFFERED 119 10.4.4 KEY DEVELOPMENTS 119 10.4.5 SWOT ANALYSIS 120 10.4.6 KEY STRATEGIES 120 10.5 INFRASCAN, INC. 121 10.5.1 COMPANY OVERVIEW 121 10.5.2 FINANCIAL OVERVIEW 121 10.5.3 PRODUCTS/SERVICES OFFERED 121 10.5.4 KEY DEVELOPMENTS 121 10.5.5 SWOT ANALYSIS 122 10.5.6 KEY STRATEGIES 122 10.6 JOHNSON & JOHNSON 123 10.6.1 COMPANY OVERVIEW 123 10.6.2 FINANCIAL OVERVIEW 123 10.6.3 PRODUCTS/SERVICES OFFERED 124 10.6.4 KEY DEVELOPMENTS 124 10.6.5 SWOT ANALYSIS 125 10.6.6 KEY STRATEGIES 125 10.7 KONINKLIJKE PHILIPS NV 126 10.7.1 COMPANY OVERVIEW 126 10.7.2 FINANCIAL OVERVIEW 127 10.7.3 PRODUCTS/SERVICES OFFERED 128 10.7.4 KEY DEVELOPMENTS 128 10.7.5 SWOT ANALYSIS 129 10.7.6 KEY STRATEGIES 129 10.8 MEDTRONIC PLC 130 10.8.1 COMPANY OVERVIEW 130 10.8.2 FINANCIAL OVERVIEW 130 10.8.3 PRODUCTS/SERVICES OFFERED 131 10.8.4 KEY DEVELOPMENTS 131 10.8.5 SWOT ANALYSIS 132 10.8.6 KEY STRATEGIES 132 10.9 SIEMENS 133 10.9.1 COMPANY OVERVIEW 133 10.9.2 FINANCIAL OVERVIEW 134 10.9.3 PRODUCTS/SERVICES OFFERED 135 10.9.4 KEY DEVELOPMENTS 135 10.9.5 SWOT ANALYSIS 136 10.9.6 KEY STRATEGIES 136 10.10 STRYKER 137 10.10.1 COMPANY OVERVIEW 137 10.10.2 FINANCIAL OVERVIEW 137 10.10.3 PRODUCTS/SERVICES OFFERED 138 10.10.4 KEY DEVELOPMENTS 138 10.10.5 SWOT ANALYSIS 139 10.10.6 KEY STRATEGIES 139 11 APPENDIX 11.1 REFERENCES 140 11.2 RELATED REPORTS 140